Hans Schreiber to Signal Transduction
This is a "connection" page, showing publications Hans Schreiber has written about Signal Transduction.
Connection Strength
0.361
-
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family. J Clin Invest. 2008 Nov; 118(11):3574-81.
Score: 0.150
-
Long-term suppression of tumor growth by TNF requires a Stat1- and IFN regulatory factor 1-dependent IFN-gamma pathway but not IL-12 or IL-18. J Immunol. 2004 Mar 01; 172(5):3243-51.
Score: 0.108
-
Fibroblasts: Dangerous travel companions. J Exp Med. 2019 03 04; 216(3):479-481.
Score: 0.076
-
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFß signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer Gene Ther. 2024 Apr; 31(4):574-585.
Score: 0.027